# Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients

> **NCT00909506** · PHASE2 · COMPLETED · sponsor: **Seoul National University Hospital** · enrollment: 105 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Placebo
- **DRUG:** Metformin
- **DRUG:** Metformin

## Key facts

- **NCT ID:** NCT00909506
- **Lead sponsor:** Seoul National University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-06
- **Primary completion:** 2011-03
- **Final completion:** 2011-12
- **Target enrollment:** 105 (ACTUAL)
- **Last updated:** 2015-07-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00909506

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00909506, "Efficacy and Safety of Adjuvant Metformin for Operable Breast Cancer Patients". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT00909506. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*